Treatment Registry
TR-0039 Not verifiedRecorded August 31, 2026Last verified September 2, 2026

Compounded semaglutide

Sold by RxPros · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Price

No price with a verifiable quote was recorded at this reading.

Visit RxPros

We earn nothing from this link. RxPros has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • August 31, 2026Entry added to the register

Sourcing and terms

PharmacyNot disclosed as of August 31, 2026
PrescriberBoth
Cancellation“Customers may cancel their subscription through the Company’s password-protected dashboard ONLY AFTER the minimum term has been concluded (3 month minimum AND/OR 6 /12 months if longer plan is selected)”
Consult feeNot disclosed as of August 31, 2026

Not yet checked: states and membership.

Recorded from rxpros.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. August 31, 2026RxPros prices the same two drugs six different ways on a single page, https://rxpros.com/. Hero cards: "Tirzepatide 22% Weight Loss* ALL DOSAGES Compounded W/ B6 (Pyridoxine) No Membership Costs. No Hidden Fees. $ 144 97 A Month* Includes doctor Visit + Shipping" and "Semaglutide ... $ 99 99 A Month* Includes doctor Visit + Shipping". Mid-page: "All Dosages Same Low Price! No Hidden Fees. Everything Included Tirzepatide Now only $249 * Semaglutide Now only $149 * *First month Introductory Discount for all new patients or save big when paid quarterly." Product cards: "Tirzepatide $ 224 99 /month *" and "Semaglutide $ 134 99 /month *", carrying the same asterisk. Comparison table: "Compound Semaglutide ... Price Starting at $99 99 /mo (Paid Annually)", "Compound Tirzepatide ... Price Starting at $144 97 /mo (Paid Annually)", "Leading Brands ... Starting at $1700/mo", each with "Quantity 4 Weekly Injections".
  2. 2. August 31, 2026RxPros locks customers into a three-month minimum, and its own policy page contradicts itself on how easy that commitment is to leave. The returns page spells out the commitment: "2. Medical Weight Loss Program Commitments Programs involving the use of Semaglutide, Tirzepatide, or similar GLP-1 medications require a three-month minimum commitment, as three months' worth of medication is dispensed upfront. Customers enrolling in these programs agree to the full three-month term, regardless of payment frequency. Early cancellation will result in a fee equal to the full retail monthly price of the remaining commitment." Elsewhere on the same page, cancellation sounds locked behind that term: "Customers may cancel their subscription through the Company’s password-protected dashboard ONLY AFTER the minimum term has been concluded (3 month minimum AND/OR 6 /12 months if longer plan is selected)". Further down, it sounds open-ended instead: "Cancellation may be completed at any time via RXPros’ secure dashboard". The page also states that "All payments for RXPros products and services are processed as automatically renewing subscription charges on a monthly basis", and that a mid-course change requested "after the prescription has been transmitted to the pharmacy will incur a $150 reprocessing fee". The home-page FAQ explains the three-month rule more simply: "In order to give you the lowest prices in the industry we ALWAYS send a 3 month supply of the medication with syringes and alcohol swabs."
  3. 3. August 31, 2026RxPros advertises easy sign-up terms on its home page: "No Insurance Required Cold Packed Shipping Cancel Subscription Anytime Telehealth Medical Team Support".
  4. 4. August 31, 2026RxPros publishes an annual rate and an introductory first-month rate, but never the per-month price of the three-month plan it says it always ships. No figure is shown for that plan until someone walks the intake to the plan screen and records what it says.
  5. 5. August 31, 2026RxPros claims FDA-approved sourcing and non-FDA-approved medication in the same breath. Its home-page FAQ reads: "We partner only with the top 503A compound pharmacies in the United States. Although our partner pharmacies are FDA approved and only use pharmaceutical-grade and highly regulated, compounded prescriptions are not FDA approved." Those two claims sit in one sentence. Asked "Can I choose which pharmacy my medication comes from?", RxPros answers: "Our proprietary technology streamlines the pharmacy selection process ... As a result, we cannot guarantee which specific pharmacy will fulfill your order."
  6. 6. August 31, 2026RxPros' footer reads "1309 Coffeen Ave Ste 15880 Sheridan, WY 82801" and "© 2025 RxPros LLC. All rights reserved." Its compounded-drug labeling is clear: "Compounded semaglutide and tirzepatide are not FDA-approved and have not undergone FDA review for safety, effectiveness, or manufacturing."
  7. 7. September 2, 2026RxPros prints its prices without a decimal separator, so the page cannot be read with confidence. Its comparison table reads “Starting at $9999/mo (Paid Annually)” and “Starting at $14497/mo (Paid Annually)”, and its product cards read “$ 99 99 A Month” and “$ 144 97 A Month” — the same two figures, rendered three different ways, none of them stating whether the amount is $99.99 or $9,999. Two more prices appear on the same page, “Semaglutide$13499/month” and “Tirzepatide$22499/month”, and a banner offers “TirzepatideNow only $249*SemaglutideNow only $149*”. No figure is recorded, because reading a decimal point into a page that does not print one would be our arithmetic rather than RxPros's price.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0039
Readings
2

Related records

Cite this entry

Treatment Registry. (2026). RxPros compounded semaglutide (TR-0039). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0039

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.